Patent ID: 6013276
Filing Date: 2000-01-11
Classification: A61K,A61P

Abstract:
A transdermal matrix system for the transdermal administration of at least one hormone, said system having a carrier and an adhesive matrix, said matrix comprising:(a) 39 to 61 parts by weight of ethylene/vinyl acetate copolymer,(b) 12 to 17 parts by weight of 2-octyldodecyl myristate,(c) 5 to 17 parts by weight of diethyl phthalate,(d) 10 to 16 parts by weight of a compound selected from N-alkyl-2-pyrrolidones in which the alkyl group is a C.sub.4 -C.sub.15 group, and(e) 1 to 12 parts by weight of at least one hormone selected from the group consisting of estrogen components and progestin components.